nodes	percent_of_prediction	percent_of_DWPC	metapath
Clomipramine—HTR2A—Gilles de la Tourette syndrome	0.809	1	CbGaD
Clomipramine—SLC6A2—autonomic nervous system—Gilles de la Tourette syndrome	0.00913	0.146	CbGeAlD
Clomipramine—HTR2A—autonomic nervous system—Gilles de la Tourette syndrome	0.00549	0.0879	CbGeAlD
Clomipramine—HRH2—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00273	0.0237	CbGpPWpGaD
Clomipramine—HTR6—Serotonin receptors—HTR2A—Gilles de la Tourette syndrome	0.00254	0.0221	CbGpPWpGaD
Clomipramine—HTR6—nervous system—Gilles de la Tourette syndrome	0.00239	0.0384	CbGeAlD
Clomipramine—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—Gilles de la Tourette syndrome	0.00234	0.0203	CbGpPWpGaD
Clomipramine—HRH2—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00233	0.0202	CbGpPWpGaD
Clomipramine—HTR2B—Serotonin receptors—HTR2A—Gilles de la Tourette syndrome	0.00232	0.0201	CbGpPWpGaD
Clomipramine—HTR6—central nervous system—Gilles de la Tourette syndrome	0.00231	0.0369	CbGeAlD
Clomipramine—HRH2—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00226	0.0196	CbGpPWpGaD
Clomipramine—HRH2—nervous system—Gilles de la Tourette syndrome	0.00219	0.0351	CbGeAlD
Clomipramine—HRH2—central nervous system—Gilles de la Tourette syndrome	0.00211	0.0338	CbGeAlD
Clomipramine—HRH2—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00211	0.0183	CbGpPWpGaD
Clomipramine—HTR6—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00209	0.0182	CbGpPWpGaD
Clomipramine—HRH2—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00196	0.017	CbGpPWpGaD
Clomipramine—GSTP1—midbrain—Gilles de la Tourette syndrome	0.00192	0.0307	CbGeAlD
Clomipramine—HTR2B—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00191	0.0166	CbGpPWpGaD
Clomipramine—HRH2—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0019	0.0165	CbGpPWpGaD
Clomipramine—HTR2C—Serotonin receptors—HTR2A—Gilles de la Tourette syndrome	0.00187	0.0162	CbGpPWpGaD
Clomipramine—HTR6—brain—Gilles de la Tourette syndrome	0.00183	0.0293	CbGeAlD
Clomipramine—SLC6A4—Monoamine Transport—SLC6A3—Gilles de la Tourette syndrome	0.00179	0.0155	CbGpPWpGaD
Clomipramine—HTR6—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00179	0.0155	CbGpPWpGaD
Clomipramine—HRH2—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00177	0.0154	CbGpPWpGaD
Clomipramine—HTR6—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00173	0.0151	CbGpPWpGaD
Clomipramine—HTR2C—midbrain—Gilles de la Tourette syndrome	0.00168	0.027	CbGeAlD
Clomipramine—HRH2—brain—Gilles de la Tourette syndrome	0.00167	0.0268	CbGeAlD
Clomipramine—HTR2B—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00163	0.0142	CbGpPWpGaD
Clomipramine—SLC6A2—Amine compound SLC transporters—SLC6A3—Gilles de la Tourette syndrome	0.00162	0.0141	CbGpPWpGaD
Clomipramine—HTR6—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00162	0.014	CbGpPWpGaD
Clomipramine—SLC6A4—midbrain—Gilles de la Tourette syndrome	0.0016	0.0256	CbGeAlD
Clomipramine—HTR2B—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00158	0.0137	CbGpPWpGaD
Clomipramine—GSTP1—nervous system—Gilles de la Tourette syndrome	0.00158	0.0252	CbGeAlD
Clomipramine—HTR2C—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00154	0.0134	CbGpPWpGaD
Clomipramine—HTR2B—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HTR2A—Gilles de la Tourette syndrome	0.00154	0.0134	CbGpPWpGaD
Clomipramine—SLC6A2—Monoamine Transport—SLC6A3—Gilles de la Tourette syndrome	0.00154	0.0134	CbGpPWpGaD
Clomipramine—GSTP1—central nervous system—Gilles de la Tourette syndrome	0.00152	0.0243	CbGeAlD
Clomipramine—HTR6—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0015	0.013	CbGpPWpGaD
Clomipramine—HRH2—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00147	0.0128	CbGpPWpGaD
Clomipramine—HTR2B—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00147	0.0128	CbGpPWpGaD
Clomipramine—HTR6—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00146	0.0127	CbGpPWpGaD
Clomipramine—HTR2C—nervous system—Gilles de la Tourette syndrome	0.00138	0.0222	CbGeAlD
Clomipramine—HTR2B—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00137	0.0119	CbGpPWpGaD
Clomipramine—HTR6—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00136	0.0118	CbGpPWpGaD
Clomipramine—HTR2A—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00134	0.0116	CbGpPWpGaD
Clomipramine—HTR2C—central nervous system—Gilles de la Tourette syndrome	0.00133	0.0213	CbGeAlD
Clomipramine—HTR2B—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00133	0.0116	CbGpPWpGaD
Clomipramine—HTR2C—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00132	0.0114	CbGpPWpGaD
Clomipramine—SLC6A4—nervous system—Gilles de la Tourette syndrome	0.00131	0.021	CbGeAlD
Clomipramine—HTR2B—nervous system—Gilles de la Tourette syndrome	0.0013	0.0208	CbGeAlD
Clomipramine—HTR2C—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00128	0.0111	CbGpPWpGaD
Clomipramine—SLC6A4—central nervous system—Gilles de la Tourette syndrome	0.00126	0.0202	CbGeAlD
Clomipramine—HTR2B—central nervous system—Gilles de la Tourette syndrome	0.00125	0.02	CbGeAlD
Clomipramine—HTR2C—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HTR2A—Gilles de la Tourette syndrome	0.00124	0.0108	CbGpPWpGaD
Clomipramine—HRH2—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00124	0.0108	CbGpPWpGaD
Clomipramine—HTR2B—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00124	0.0108	CbGpPWpGaD
Clomipramine—ADRA2A—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00122	0.0106	CbGpPWpGaD
Clomipramine—GSTP1—brain—Gilles de la Tourette syndrome	0.0012	0.0193	CbGeAlD
Clomipramine—HTR2C—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00119	0.0103	CbGpPWpGaD
Clomipramine—SLC6A2—nervous system—Gilles de la Tourette syndrome	0.00115	0.0185	CbGeAlD
Clomipramine—HTR2A—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00114	0.00992	CbGpPWpGaD
Clomipramine—HTR6—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00113	0.00982	CbGpPWpGaD
Clomipramine—SLC6A2—central nervous system—Gilles de la Tourette syndrome	0.00111	0.0178	CbGeAlD
Clomipramine—HTR2A—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00111	0.00963	CbGpPWpGaD
Clomipramine—HTR2C—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00111	0.0096	CbGpPWpGaD
Clomipramine—HTR2C—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00107	0.00932	CbGpPWpGaD
Clomipramine—HTR2C—brain—Gilles de la Tourette syndrome	0.00106	0.0169	CbGeAlD
Clomipramine—ADRA2A—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00104	0.00902	CbGpPWpGaD
Clomipramine—HTR2A—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00103	0.00897	CbGpPWpGaD
Clomipramine—HTR2B—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00103	0.00897	CbGpPWpGaD
Clomipramine—ALB—brain—Gilles de la Tourette syndrome	0.00103	0.0165	CbGeAlD
Clomipramine—ADRA2A—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00101	0.00876	CbGpPWpGaD
Clomipramine—SLC6A4—brain—Gilles de la Tourette syndrome	0.001	0.0161	CbGeAlD
Clomipramine—HTR2C—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.001	0.00868	CbGpPWpGaD
Clomipramine—HTR2B—brain—Gilles de la Tourette syndrome	0.000994	0.0159	CbGeAlD
Clomipramine—ADRA2A—midbrain—Gilles de la Tourette syndrome	0.000993	0.0159	CbGeAlD
Clomipramine—HTR2A—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00096	0.00834	CbGpPWpGaD
Clomipramine—HTR6—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000951	0.00826	CbGpPWpGaD
Clomipramine—ADRA2A—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00094	0.00816	CbGpPWpGaD
Clomipramine—HTR2A—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.000932	0.00809	CbGpPWpGaD
Clomipramine—SLC6A2—brain—Gilles de la Tourette syndrome	0.000883	0.0141	CbGeAlD
Clomipramine—GSTP1—NRF2 pathway—SLC6A3—Gilles de la Tourette syndrome	0.000874	0.00759	CbGpPWpGaD
Clomipramine—ADRA2A—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.000873	0.00758	CbGpPWpGaD
Clomipramine—HTR2A—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.000868	0.00754	CbGpPWpGaD
Clomipramine—HTR2B—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000868	0.00754	CbGpPWpGaD
Clomipramine—ADRA2A—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.000848	0.00736	CbGpPWpGaD
Clomipramine—HTR2A—midbrain—Gilles de la Tourette syndrome	0.000844	0.0135	CbGeAlD
Clomipramine—HTR2C—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000833	0.00723	CbGpPWpGaD
Clomipramine—ADRA2A—nervous system—Gilles de la Tourette syndrome	0.000816	0.0131	CbGeAlD
Clomipramine—ADRA2A—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00079	0.00686	CbGpPWpGaD
Clomipramine—ADRA2A—central nervous system—Gilles de la Tourette syndrome	0.000786	0.0126	CbGeAlD
Clomipramine—HTR2C—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0007	0.00608	CbGpPWpGaD
Clomipramine—HTR2A—nervous system—Gilles de la Tourette syndrome	0.000694	0.0111	CbGeAlD
Clomipramine—HTR2A—central nervous system—Gilles de la Tourette syndrome	0.000668	0.0107	CbGeAlD
Clomipramine—ADRA2A—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000658	0.00571	CbGpPWpGaD
Clomipramine—CYP3A4—nervous system—Gilles de la Tourette syndrome	0.000643	0.0103	CbGeAlD
Clomipramine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Gilles de la Tourette syndrome	0.000634	0.0055	CbGpPWpGaD
Clomipramine—CYP2D6—nervous system—Gilles de la Tourette syndrome	0.000632	0.0101	CbGeAlD
Clomipramine—ADRA2A—brain—Gilles de la Tourette syndrome	0.000624	0.00999	CbGeAlD
Clomipramine—CYP3A4—central nervous system—Gilles de la Tourette syndrome	0.000619	0.00991	CbGeAlD
Clomipramine—CYP2D6—central nervous system—Gilles de la Tourette syndrome	0.000609	0.00975	CbGeAlD
Clomipramine—ABCB1—midbrain—Gilles de la Tourette syndrome	0.000553	0.00886	CbGeAlD
Clomipramine—ADRA2A—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000553	0.0048	CbGpPWpGaD
Clomipramine—SLC6A4—NRF2 pathway—SLC6A3—Gilles de la Tourette syndrome	0.000531	0.00461	CbGpPWpGaD
Clomipramine—HTR2A—brain—Gilles de la Tourette syndrome	0.000531	0.0085	CbGeAlD
Clomipramine—HTR2A—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.000507	0.0044	CbGpPWpGaD
Clomipramine—HTR2A—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.000492	0.00428	CbGpPWpGaD
Clomipramine—CYP2D6—brain—Gilles de la Tourette syndrome	0.000483	0.00774	CbGeAlD
Clomipramine—SLC6A2—NRF2 pathway—SLC6A3—Gilles de la Tourette syndrome	0.000457	0.00397	CbGpPWpGaD
Clomipramine—ABCB1—nervous system—Gilles de la Tourette syndrome	0.000455	0.00729	CbGeAlD
Clomipramine—Chlorphenamine—SLC6A3—Gilles de la Tourette syndrome	0.000452	0.035	CrCbGaD
Clomipramine—HRH2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000449	0.0039	CbGpPWpGaD
Clomipramine—SLC6A4—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.000447	0.00388	CbGpPWpGaD
Clomipramine—Propiomazine—DRD4—Gilles de la Tourette syndrome	0.000445	0.0344	CrCbGaD
Clomipramine—Prochlorperazine—DRD3—Gilles de la Tourette syndrome	0.000441	0.0341	CrCbGaD
Clomipramine—ABCB1—central nervous system—Gilles de la Tourette syndrome	0.000438	0.00701	CbGeAlD
Clomipramine—HRH2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000436	0.00379	CbGpPWpGaD
Clomipramine—SLC6A4—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.000434	0.00377	CbGpPWpGaD
Clomipramine—HRH2—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000406	0.00353	CbGpPWpGaD
Clomipramine—SLC6A4—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.000404	0.00351	CbGpPWpGaD
Clomipramine—Cyamemazine—HTR2A—Gilles de la Tourette syndrome	0.0004	0.0309	CrCbGaD
Clomipramine—HRH2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000385	0.00334	CbGpPWpGaD
Clomipramine—Methotrimeprazine—DRD4—Gilles de la Tourette syndrome	0.000381	0.0294	CrCbGaD
Clomipramine—GSTP1—Metabolism—HDC—Gilles de la Tourette syndrome	0.000377	0.00327	CbGpPWpGaD
Clomipramine—HRH2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000374	0.00325	CbGpPWpGaD
Clomipramine—Chlorprothixene—DRD3—Gilles de la Tourette syndrome	0.000363	0.0281	CrCbGaD
Clomipramine—Triflupromazine—DRD2—Gilles de la Tourette syndrome	0.000359	0.0278	CrCbGaD
Clomipramine—HRH2—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000348	0.00302	CbGpPWpGaD
Clomipramine—ABCB1—brain—Gilles de la Tourette syndrome	0.000348	0.00557	CbGeAlD
Clomipramine—SLC6A4—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.000347	0.00301	CbGpPWpGaD
Clomipramine—HTR6—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000345	0.00299	CbGpPWpGaD
Clomipramine—HTR6—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000335	0.00291	CbGpPWpGaD
Clomipramine—Acepromazine—DRD2—Gilles de la Tourette syndrome	0.000332	0.0257	CrCbGaD
Clomipramine—Promazine—DRD4—Gilles de la Tourette syndrome	0.00033	0.0255	CrCbGaD
Clomipramine—Methotrimeprazine—DRD3—Gilles de la Tourette syndrome	0.000328	0.0254	CrCbGaD
Clomipramine—Thioproperazine—DRD2—Gilles de la Tourette syndrome	0.000325	0.0251	CrCbGaD
Clomipramine—Pipotiazine—DRD2—Gilles de la Tourette syndrome	0.000319	0.0247	CrCbGaD
Clomipramine—HTR2B—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000315	0.00273	CbGpPWpGaD
Clomipramine—Trimipramine—SLC6A3—Gilles de la Tourette syndrome	0.000312	0.0242	CrCbGaD
Clomipramine—HTR6—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000312	0.00271	CbGpPWpGaD
Clomipramine—HTR2B—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000305	0.00265	CbGpPWpGaD
Clomipramine—Prochlorperazine—DRD2—Gilles de la Tourette syndrome	0.000305	0.0236	CrCbGaD
Clomipramine—HTR6—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000295	0.00256	CbGpPWpGaD
Clomipramine—HRH2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000293	0.00255	CbGpPWpGaD
Clomipramine—Chlorpromazine—DRD4—Gilles de la Tourette syndrome	0.00029	0.0225	CrCbGaD
Clomipramine—SLC6A2—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.000288	0.0025	CbGpPWpGaD
Clomipramine—HTR6—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000287	0.00249	CbGpPWpGaD
Clomipramine—HRH2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000285	0.00247	CbGpPWpGaD
Clomipramine—HRH2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000285	0.00247	CbGpPWpGaD
Clomipramine—HTR2B—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000284	0.00247	CbGpPWpGaD
Clomipramine—Desipramine—SLC6A3—Gilles de la Tourette syndrome	0.000273	0.0211	CrCbGaD
Clomipramine—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00027	0.00234	CbGpPWpGaD
Clomipramine—HTR6—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000267	0.00232	CbGpPWpGaD
Clomipramine—Propiomazine—DRD2—Gilles de la Tourette syndrome	0.000266	0.0206	CrCbGaD
Clomipramine—HRH2—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000265	0.0023	CbGpPWpGaD
Clomipramine—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000262	0.00227	CbGpPWpGaD
Clomipramine—HTR2B—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000258	0.00224	CbGpPWpGaD
Clomipramine—Acepromazine—HTR2A—Gilles de la Tourette syndrome	0.000257	0.0199	CrCbGaD
Clomipramine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000254	0.0022	CbGpPWpGaD
Clomipramine—Chlorprothixene—DRD2—Gilles de la Tourette syndrome	0.000251	0.0195	CrCbGaD
Clomipramine—Thioproperazine—HTR2A—Gilles de la Tourette syndrome	0.000251	0.0194	CrCbGaD
Clomipramine—Chlorpromazine—DRD3—Gilles de la Tourette syndrome	0.00025	0.0194	CrCbGaD
Clomipramine—Amitriptyline—DRD3—Gilles de la Tourette syndrome	0.000247	0.0191	CrCbGaD
Clomipramine—Pipotiazine—HTR2A—Gilles de la Tourette syndrome	0.000247	0.0191	CrCbGaD
Clomipramine—Nortriptyline—DRD2—Gilles de la Tourette syndrome	0.000247	0.0191	CrCbGaD
Clomipramine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000246	0.00214	CbGpPWpGaD
Clomipramine—HRH2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000244	0.00212	CbGpPWpGaD
Clomipramine—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000244	0.00212	CbGpPWpGaD
Clomipramine—Thioridazine—DRD2—Gilles de la Tourette syndrome	0.000238	0.0184	CrCbGaD
Clomipramine—Trimipramine—DRD2—Gilles de la Tourette syndrome	0.000232	0.018	CrCbGaD
Clomipramine—Imipramine—SLC6A3—Gilles de la Tourette syndrome	0.000232	0.0179	CrCbGaD
Clomipramine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000231	0.002	CbGpPWpGaD
Clomipramine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00023	0.00199	CbGpPWpGaD
Clomipramine—Methotrimeprazine—DRD2—Gilles de la Tourette syndrome	0.000227	0.0176	CrCbGaD
Clomipramine—HTR6—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000225	0.00195	CbGpPWpGaD
Clomipramine—Promethazine—DRD2—Gilles de la Tourette syndrome	0.000224	0.0173	CrCbGaD
Clomipramine—Doxepin—DRD2—Gilles de la Tourette syndrome	0.000221	0.0171	CrCbGaD
Clomipramine—Trifluoperazine—DRD2—Gilles de la Tourette syndrome	0.000221	0.0171	CrCbGaD
Clomipramine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00022	0.00191	CbGpPWpGaD
Clomipramine—Perphenazine—DRD2—Gilles de la Tourette syndrome	0.000218	0.0169	CrCbGaD
Clomipramine—HTR6—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000218	0.0019	CbGpPWpGaD
Clomipramine—HTR6—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000218	0.0019	CbGpPWpGaD
Clomipramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000217	0.00189	CbGpPWpGaD
Clomipramine—ADRA2A—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000216	0.00188	CbGpPWpGaD
Clomipramine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000214	0.00186	CbGpPWpGaD
Clomipramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000211	0.00183	CbGpPWpGaD
Clomipramine—ADRA2A—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00021	0.00182	CbGpPWpGaD
Clomipramine—HTR2C—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000208	0.00181	CbGpPWpGaD
Clomipramine—HTR2B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000205	0.00178	CbGpPWpGaD
Clomipramine—Propiomazine—HTR2A—Gilles de la Tourette syndrome	0.000205	0.0159	CrCbGaD
Clomipramine—HTR6—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000203	0.00177	CbGpPWpGaD
Clomipramine—Desipramine—DRD2—Gilles de la Tourette syndrome	0.000203	0.0157	CrCbGaD
Clomipramine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000201	0.00174	CbGpPWpGaD
Clomipramine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000199	0.00173	CbGpPWpGaD
Clomipramine—HTR2B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000199	0.00173	CbGpPWpGaD
Clomipramine—HTR2B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000199	0.00173	CbGpPWpGaD
Clomipramine—Promazine—DRD2—Gilles de la Tourette syndrome	0.000197	0.0152	CrCbGaD
Clomipramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000197	0.00171	CbGpPWpGaD
Clomipramine—ADRA2A—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.000195	0.0017	CbGpPWpGaD
Clomipramine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000195	0.00169	CbGpPWpGaD
Clomipramine—Chlorprothixene—HTR2A—Gilles de la Tourette syndrome	0.000194	0.015	CrCbGaD
Clomipramine—Nortriptyline—HTR2A—Gilles de la Tourette syndrome	0.000191	0.0148	CrCbGaD
Clomipramine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000189	0.00164	CbGpPWpGaD
Clomipramine—HTR6—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000187	0.00162	CbGpPWpGaD
Clomipramine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000186	0.00162	CbGpPWpGaD
Clomipramine—HRH2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000186	0.00161	CbGpPWpGaD
Clomipramine—HTR2B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000186	0.00161	CbGpPWpGaD
Clomipramine—Thioridazine—HTR2A—Gilles de la Tourette syndrome	0.000184	0.0142	CrCbGaD
Clomipramine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000183	0.00159	CbGpPWpGaD
Clomipramine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000181	0.00157	CbGpPWpGaD
Clomipramine—Trimipramine—HTR2A—Gilles de la Tourette syndrome	0.00018	0.0139	CrCbGaD
Clomipramine—Methotrimeprazine—HTR2A—Gilles de la Tourette syndrome	0.000175	0.0136	CrCbGaD
Clomipramine—Chlorpromazine—DRD2—Gilles de la Tourette syndrome	0.000173	0.0134	CrCbGaD
Clomipramine—Promethazine—HTR2A—Gilles de la Tourette syndrome	0.000173	0.0134	CrCbGaD
Clomipramine—Imipramine—DRD2—Gilles de la Tourette syndrome	0.000172	0.0133	CrCbGaD
Clomipramine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000172	0.00149	CbGpPWpGaD
Clomipramine—Amitriptyline—DRD2—Gilles de la Tourette syndrome	0.000171	0.0133	CrCbGaD
Clomipramine—Doxepin—HTR2A—Gilles de la Tourette syndrome	0.000171	0.0132	CrCbGaD
Clomipramine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000171	0.00148	CbGpPWpGaD
Clomipramine—HTR2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000171	0.00148	CbGpPWpGaD
Clomipramine—Trifluoperazine—HTR2A—Gilles de la Tourette syndrome	0.000171	0.0132	CrCbGaD
Clomipramine—Perphenazine—HTR2A—Gilles de la Tourette syndrome	0.000169	0.0131	CrCbGaD
Clomipramine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000167	0.00145	CbGpPWpGaD
Clomipramine—HRH2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000166	0.00144	CbGpPWpGaD
Clomipramine—HTR2C—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000166	0.00144	CbGpPWpGaD
Clomipramine—HRH2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000161	0.0014	CbGpPWpGaD
Clomipramine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000161	0.0014	CbGpPWpGaD
Clomipramine—HTR2C—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000161	0.0014	CbGpPWpGaD
Clomipramine—Desipramine—HTR2A—Gilles de la Tourette syndrome	0.000157	0.0121	CrCbGaD
Clomipramine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000155	0.00135	CbGpPWpGaD
Clomipramine—Promazine—HTR2A—Gilles de la Tourette syndrome	0.000152	0.0118	CrCbGaD
Clomipramine—HRH2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00015	0.00131	CbGpPWpGaD
Clomipramine—HRH2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00015	0.0013	CbGpPWpGaD
Clomipramine—HTR2C—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00015	0.0013	CbGpPWpGaD
Clomipramine—SLC6A2—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000146	0.00127	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000146	0.00127	CbGpPWpGaD
Clomipramine—ALB—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.000145	0.00126	CbGpPWpGaD
Clomipramine—HTR2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000144	0.00125	CbGpPWpGaD
Clomipramine—HTR6—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000142	0.00124	CbGpPWpGaD
Clomipramine—HTR2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00014	0.00121	CbGpPWpGaD
Clomipramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000138	0.0012	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000136	0.00118	CbGpPWpGaD
Clomipramine—Chlorpromazine—HTR2A—Gilles de la Tourette syndrome	0.000134	0.0104	CrCbGaD
Clomipramine—Imipramine—HTR2A—Gilles de la Tourette syndrome	0.000133	0.0103	CrCbGaD
Clomipramine—Amitriptyline—HTR2A—Gilles de la Tourette syndrome	0.000132	0.0102	CrCbGaD
Clomipramine—ADRA2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000131	0.00114	CbGpPWpGaD
Clomipramine—HTR2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00013	0.00113	CbGpPWpGaD
Clomipramine—HTR2B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00013	0.00113	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000127	0.0011	CbGpPWpGaD
Clomipramine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000127	0.0011	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000127	0.0011	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—HDC—Gilles de la Tourette syndrome	0.000125	0.00109	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000123	0.00107	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000118	0.00103	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000116	0.00101	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000115	0.001	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000115	0.000998	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000113	0.000978	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000112	0.000973	CbGpPWpGaD
Clomipramine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000109	0.000945	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000105	0.000915	CbGpPWpGaD
Clomipramine—HRH2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000105	0.000911	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000105	0.000911	CbGpPWpGaD
Clomipramine—HTR2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000105	0.000911	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000104	0.000906	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000102	0.000888	CbGpPWpGaD
Clomipramine—ALB—Metabolism—HDC—Gilles de la Tourette syndrome	9.9e-05	0.00086	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	9.53e-05	0.000827	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	9.53e-05	0.000827	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	9.36e-05	0.000813	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	9.08e-05	0.000789	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	8.89e-05	0.000772	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—HDC—Gilles de la Tourette syndrome	8.89e-05	0.000772	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—HDC—Gilles de la Tourette syndrome	8.67e-05	0.000753	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	8.63e-05	0.000749	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	8.5e-05	0.000738	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	8.46e-05	0.000735	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	8.29e-05	0.000719	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	8.25e-05	0.000716	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	8.17e-05	0.00071	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	8.13e-05	0.000706	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	8.05e-05	0.000699	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	8.04e-05	0.000698	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	7.89e-05	0.000685	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	7.68e-05	0.000667	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	7.39e-05	0.000642	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	7.38e-05	0.000641	CbGpPWpGaD
Clomipramine—ALB—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	7.35e-05	0.000639	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	7.35e-05	0.000638	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	7.35e-05	0.000638	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	7.31e-05	0.000635	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	7.18e-05	0.000623	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	7.16e-05	0.000622	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—HDC—Gilles de la Tourette syndrome	6.92e-05	0.000601	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	6.82e-05	0.000592	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	6.71e-05	0.000583	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	6.69e-05	0.000581	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	6.67e-05	0.000579	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	6.67e-05	0.000579	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	6.62e-05	0.000575	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	6.52e-05	0.000566	CbGpPWpGaD
Clomipramine—ABCB1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	6.44e-05	0.00056	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	6.22e-05	0.00054	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	6.16e-05	0.000535	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	6.07e-05	0.000527	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	6.04e-05	0.000525	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	5.93e-05	0.000515	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	5.63e-05	0.000489	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	5.63e-05	0.000489	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	5.38e-05	0.000467	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—HDC—Gilles de la Tourette syndrome	5.34e-05	0.000464	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	5.02e-05	0.000436	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	4.87e-05	0.000423	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	4.68e-05	0.000407	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	4.54e-05	0.000394	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	4.36e-05	0.000379	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	4.32e-05	0.000375	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	4.25e-05	0.000369	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	4.23e-05	0.000367	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.97e-05	0.000344	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.94e-05	0.000342	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	3.94e-05	0.000342	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.85e-05	0.000334	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.59e-05	0.000311	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	3.18e-05	0.000276	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.51e-05	0.000218	CbGpPWpGaD
